Atlas Trials

Median Effective Dose of Remifentanil for the Prevention of Myoclonus Induced by Etomidate Injection

Clinical trial NCT05754762 · UNKNOWN

Trial details

NCT number
NCT05754762
Sponsor
Yangzhou University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
EtomidateMyoclonus
Start date
2023-03-01
Primary completion
2023-07-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.